1989
Detection of hepatotoxicity associated with methotrexate therapy for psoriasis
Search citation statements
Paper Sections
Select...
11
0
0
0
Citation Types
0
1
0
0
Year Published
1995
2021
Publication Types
Select...
11
Relationship
0
11
Authors
Journals
Cited by 11 publications
(1 citation statement)
References 0 publications
0
1
0
0
“…The pathogenesis of cumulative methotrexate hepatotoxicity is not completely understood. Studies have shown that the pathologic fibrotic changes observed with methotrexate treatment are mostly non-aggressive[ 14 ] and potentially reversible after withdrawal of methotrexate treatment, defined as a period of 6 months or more without administration of methotrexate. [ 15 ] Moreover, a systematic review of liver abnormalities in patients with psoriasis on methotrexate showed that cumulative dose and duration of methotrexate therapy were not associated with fibrosis/cirrhosis on biopsy (as independent variables).…”
mentioning
confidence: 99%
“…The pathogenesis of cumulative methotrexate hepatotoxicity is not completely understood. Studies have shown that the pathologic fibrotic changes observed with methotrexate treatment are mostly non-aggressive[ 14 ] and potentially reversible after withdrawal of methotrexate treatment, defined as a period of 6 months or more without administration of methotrexate. [ 15 ] Moreover, a systematic review of liver abnormalities in patients with psoriasis on methotrexate showed that cumulative dose and duration of methotrexate therapy were not associated with fibrosis/cirrhosis on biopsy (as independent variables).…”
mentioning
confidence: 99%
